FAME at 5 years: FFR Should Guide All Multivessel PCIs

Though the benefit of FFR (fractional flow reserve) over angiography is statistically important only over the first 2 years, this pattern is maintained at long term according to FAME 5 year follow up, presented at the ECS and simultaneously published in The Lancet.

Between the second and fifth year, the number of patients at risk is so low that the difference between strategies loses statistical significance; however, risk evolves at the same rate in both groups and, therefore, the original difference in favor of FFR is no less significant.

The FAME trial randomized 1.005 patients receiving DES to treat multivessel disease (>50% stenosis in at least 2 of 3 major coronary arteries) in 20 centers in Europe and US. Patients were randomized to angiography guided PCI (n = 496) vs. FFR guided PCI (n = 509). In the angiography guided group, all ≥50% lesions were treated with DES while in the FFR guided group, only ≤0.80 lesions were treated.

At 5 years, the completed follow up data became available for 86% of patients of the FAME cohort. MACE rates (major adverse cardiac events) (primary end point, death, MI and repeat revascularization) and all cause death/MI and cardiac death/ MI were similar between both arms of the study (angiography 31% vs FFR 28%; p=0.31).

Kaplan-Meier survival curves reveal the difference between FFR and angiography remains stable during the 5 year follow up.

The multivariable analysis showed a correlation between men and strategy (p for intervention = 0.027), FFR being associated to a lower risk of MACE at 5 years in men.

Nico H.J. Pijls

More articles by this author

OPTIDUAL: Dual Antiaggregation Not Beneficial after 12 Months.

Extending dual antiaggregation therapy (DAT) from 12 to 48 months appears not to offer extra protection after DES implantation in patients with no adverse...

Meta-analysis of prolonged DAT after DES

Extending the antiaggregation therapy over a year reduces adverse events in patients with a history of AMI, according to this meta-analysis simultaneously published in...

BACC: Protocol for Rapid Diagnosis of Myocardial Infraction

The 1-hour algorithm using high-sensitivity troponin measurement for rapid diagnosis of AMI is safe. To carry out the BACC study (Biomarkers in Acute Cardiovascular Care)...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...